Your browser doesn't support javascript.
loading
Relevance of the MHC region for breast cancer susceptibility in Asians.
Ho, Peh Joo; Khng, Alexis Jiaying; Tan, Benita Kiat-Tee; Tan, Ern Yu; Tan, Su-Ming; Tan, Veronique Kiak Mien; Lim, Geok Hoon; Aronson, Kristan J; Chan, Tsun L; Choi, Ji-Yeob; Dennis, Joe; Ho, Weang-Kee; Hou, Ming-Feng; Ito, Hidemi; Iwasaki, Motoki; John, Esther M; Kang, Daehee; Kim, Sung-Won; Kurian, Allison W; Kwong, Ava; Lophatananon, Artitaya; Matsuo, Keitaro; Mohd-Taib, Nur Aishah; Muir, Kenneth; Murphy, Rachel A; Park, Sue K; Shen, Chen-Yang; Shu, Xiao-Ou; Teo, Soo Hwang; Wang, Qin; Yamaji, Taiki; Zheng, Wei; Bolla, Manjeet K; Dunning, Alison M; Easton, Douglas F; Pharoah, Paul D P; Hartman, Mikael; Li, Jingmei.
Afiliação
  • Ho PJ; Women's Health and Genetics, Genome Institute of Singapore, 60 Biopolis Street, Genome, #02-01, Singapore, 138672, Singapore.
  • Khng AJ; Saw Swee Hock School of Public Health, National University of Singapore and National University Health System, Singapore, 119077, Singapore.
  • Tan BK; Department of Surgery, National University Health System, Singapore, 119228, Singapore.
  • Tan EY; Women's Health and Genetics, Genome Institute of Singapore, 60 Biopolis Street, Genome, #02-01, Singapore, 138672, Singapore.
  • Tan SM; Department of Breast Surgery, Singapore General Hospital, Singapore, Singapore.
  • Tan VKM; Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Lim GH; Department of General Surgery, Sengkang General Hospital, Singapore, Singapore.
  • Aronson KJ; Department of General Surgery, Tan Tock Seng Hospital, Singapore, 308433, Singapore.
  • Chan TL; Lee Kong Chian School of Medicine, Singapore, Singapore.
  • Choi JY; Institute of Molecular and Cell Biology, Singapore, Singapore.
  • Dennis J; Division of Breast Surgery, Changi General Hospital, Singapore, Singapore.
  • Ho WK; Department of Breast Surgery, Singapore General Hospital, Singapore, Singapore.
  • Hou MF; Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Ito H; KK Breast Department, KK Women's and Children's Hospital, Singapore, 229899, Singapore.
  • Iwasaki M; Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, ON, K7L 3N6, Canada.
  • John EM; Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong, Hong Kong.
  • Kang D; Department of Molecular Pathology, Hong Kong Sanatorium and Hospital, Hong Kong, Hong Kong.
  • Kim SW; Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, 03080, Korea.
  • Kurian AW; Cancer Research Institute, Seoul National University, Seoul, 03080, Korea.
  • Kwong A; Institute of Health Policy and Management, Seoul National University Medical Research Center, Seoul, 03080, Korea.
  • Lophatananon A; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, CB1 8RN, UK.
  • Matsuo K; Department of Mathematical Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia Campus, 43500, Semenyih, Selangor, Malaysia.
  • Mohd-Taib NA; Breast Cancer Research Programme, Cancer Research Malaysia, 47500, Subang Jaya, Selangor, Malaysia.
  • Muir K; Department of Surgery, Kaohsiung Municipal Hsiao-Kang Hospital, Kao-hsiung, 812, Taiwan.
  • Murphy RA; Division of Cancer Information and Control, Aichi Cancer Center Research Institute, Nagoya, 464-8681, Japan.
  • Park SK; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, Nagoya, 466-8550, Japan.
  • Shen CY; Division of Epidemiology, Center for Public Health Sciences, National Cancer Center, Tokyo, 104-0045, Japan.
  • Shu XO; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, 94305, USA.
  • Teo SH; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94304, USA.
  • Wang Q; Cancer Research Institute, Seoul National University, Seoul, 03080, Korea.
  • Yamaji T; Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, 03080, Korea.
  • Zheng W; Department of Surgery, Daerim Saint Mary's Hospital, Seoul, 07442, Korea.
  • Bolla MK; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, 94305, USA.
  • Dunning AM; Department of Medicine, Division of Oncology, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94304, USA.
  • Easton DF; Hong Kong Hereditary Breast Cancer Family Registry, Hong Kong, Hong Kong.
  • Pharoah PDP; Department of Surgery, The University of Hong Kong, Hong Kong, Hong Kong.
  • Hartman M; Department of Surgery and Cancer Genetics Center, Hong Kong Sanatorium and Hospital, Hong Kong, Hong Kong.
  • Li J; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PL, UK.
Breast Cancer ; 29(5): 869-879, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35543923

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antígenos HLA Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura País de publicação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antígenos HLA Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Singapura País de publicação: Japão